Evidence map›Paper›PMID 34534255›Full record

ArticlePloS one2021

The inhibitory effects of toothpaste and mouthwash ingredients on the interaction between the SARS-CoV-2 spike protein and ACE2, and the protease activity of TMPRSS2 in vitro.

Riho Tateyama-Makino, Mari Abe-Yutori, Taku Iwamoto, Kota Tsutsumi, Motonori Tsuji, Satoru Morishita, Kei Kurita, Yukio Yamamoto, Eiji Nishinaga, Keiichi Tsukinoki

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Ingredients in Commercially Available Mouthwashes.International dental journal · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Relationship between Toothpaste Dilution Ratio and Droplets Generated during Tooth-Brushing.International journal of environmental research and public health · 2022
    Article
  11. Computational screening of camostat and related compounds against human TMPRSS2: A potential treatment of COVID-19.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  12. Oral Pathology in COVID-19 and SARS-CoV-2 Infection-Molecular Aspects.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Riho Tateyama-MakinoResearch & Development Headquarters, Lion Corporation, Edogawa-ku, Tokyo, Japan.ORCID 0000-0001-5206-8339
Mari Abe-YutoriResearch & Development Headquarters, Lion Corporation, Edogawa-ku, Tokyo, Japan.
Taku IwamotoResearch & Development Headquarters, Lion Corporation, Edogawa-ku, Tokyo, Japan.
Kota TsutsumiResearch & Development Headquarters, Lion Corporation, Edogawa-ku, Tokyo, Japan.ORCID 0000-0003-1371-2915
Motonori TsujiInstitute of Molecular Function, Misato-shi, Saitama, Japan.ORCID 0000-0003-0734-0334
Satoru MorishitaResearch & Development Headquarters, Lion Corporation, Edogawa-ku, Tokyo, Japan.
Kei KuritaResearch & Development Headquarters, Lion Corporation, Edogawa-ku, Tokyo, Japan.
Yukio YamamotoResearch & Development Headquarters, Lion Corporation, Edogawa-ku, Tokyo, Japan.
Eiji NishinagaResearch & Development Headquarters, Lion Corporation, Edogawa-ku, Tokyo, Japan.
Keiichi TsukinokiDivision of Environmental Pathology, Department of Oral Science, Kanagawa Dental University, Yokosuka, Kanagawa, Japan.
Lion Corporation (Japan) · JPKanagawa Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 enters host cells when the viral spike protein is cleaved by transmembrane protease serine 2 (TMPRSS2) after binding to the host angiotensin-converting enzyme 2 (ACE2). Since ACE2 and TMPRSS2 are expressed in the tongue and gingival mucosa, the oral cavity is a potential entry point for SARS-CoV-2. This study evaluated the inhibitory effects of general ingredients of toothpastes and mouthwashes on the spike protein-ACE2 interaction and the TMPRSS2 protease activity using an in vitro assay. Both assays detected inhibitory effects of sodium tetradecene sulfonate, sodium N-lauroyl-N-methyltaurate, sodium N-lauroylsarcosinate, sodium dodecyl sulfate, and copper gluconate. Molecular docking simulations suggested that these ingredients could bind to inhibitor-binding site of ACE2. Furthermore, tranexamic acid exerted inhibitory effects on TMPRSS2 protease activity. Our findings suggest that these toothpaste and mouthwash ingredients could help prevent SARS-CoV-2 infection.

Indexed as

Angiotensin-Converting Enzyme 2COVID-19HumansMouthwashesOral HygieneSARS-CoV-2Serine EndopeptidasesSpike Glycoprotein, CoronavirusToothpastesVirus InternalizationACE2 protein, humanAngiotensin-Converting Enzyme 2MouthwashesSerine EndopeptidasesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2TMPRSS2 protein, humanToothpastes

Identifiers

PMID34534255
PMCPMC8448299
OpenAlexW3200517238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.